Table I.
Clinical status | Controls, n (%) | Cirrhosis, n (%) | HCC, n (%) |
Number of subjects | 325 | 78 | 198 |
Age | |||
≤30 | 84 (26) | 20 (25.5) | 23 (12) |
31–40 | 62 (19) | 17 (22) | 36 (18) |
41–50 | 54 (17) | 21 (27) | 54 (27) |
≥51 | 125 (38) | 20 (25.5) | 85 (43) |
Sex | |||
Men | 224 (69) | 50 (64) | 160 (81) |
Women | 101 (31) | 28 (36) | 38 (19) |
HBsAg | |||
Positive | 43 (13) | 44 (56) | 106 (54) |
Negative | 274 (85) | 34 (44) | 88 (44) |
N/A | 8 (2) | 0 (0) | 4 (2) |
HBeAga | |||
Positive | 2 (5) | 14 (32) | 17 (16) |
Negative | 39 (90) | 27 (61) | 87 (82) |
N/A | 2 (5) | 3 (7) | 2 (2) |
Viral loadsa | |||
> Copies/mlb (n) | 2.5.103 (22) | 9.5.106 (29) | 3.4.105 (76) |
> <200, n (%) | 21 (49) | 15 (34) | 30 (28) |
N/A: not available.
only for HBsAg-positive subjects.
Median.